During the study period, 67 patients with unresectable advanced or recurrent CRC received anti-EGFR antibody drugs as cancer chemotherapy for the first time; none of them reported skin diseases, such as psoriasis or atopic dermatitis. The gene discussed is EGFR; the disease is colorectal carcinoma.